153 related articles for article (PubMed ID: 71870)
21. [Neoadjuvant treatment of Ewing's sarcoma: results obtained in 122 patients treated with a 6-drug chemotherapeutic protocol (vincristine, adriamycin, cyclophosphamide, dactinomycin, ifosfamide and etoposide)].
Bacci G; Ferrari S; Rosito P; Barbieri E; Mercuri M; Brach del Prever A; Iantorno D; Forni C; Campanacci M
Minerva Pediatr; 1995 Nov; 47(11):457-69. PubMed ID: 8684341
[TBL] [Abstract][Full Text] [Related]
22. [Results of combined therapy in rhabdomyosarcoma in children].
Lobo F; Vargas G; Camacho A; Jiménez E; Jiménez R; Carrillo J
Bol Med Hosp Infant Mex; 1979; 36(2):337-46. PubMed ID: 758202
[TBL] [Abstract][Full Text] [Related]
23. [Therapeutic effect of adjuvant combination chemotherapy in the treatment of 8 cases of childhood soft-tissue sarcoma].
Imashuku S; Todo S; Esumi N; Yamanaka H; Iwasaku M; Morioka Y; Ogita S; Tokiwa K; Fukumochi Y; Fujita K
Gan To Kagaku Ryoho; 1987 Apr; 14(4):1063-8. PubMed ID: 3566303
[TBL] [Abstract][Full Text] [Related]
24. Combination chemotherapy for embryonal rhabdomyosarcoma.
Wilbur JR
Cancer Chemother Rep; 1974; 58(2):281-4. PubMed ID: 4830502
[No Abstract] [Full Text] [Related]
25. Rhabdomyosarcoma of the bile ducts.
O'Meara A
Z Kinderchir; 1981 Aug; 33(4):366-8. PubMed ID: 7324581
[TBL] [Abstract][Full Text] [Related]
26. Rhabdomyosarcoma of the ear and temporal bone.
Wiatrak BJ; Pensak ML
Laryngoscope; 1989 Nov; 99(11):1188-92. PubMed ID: 2811561
[TBL] [Abstract][Full Text] [Related]
27. A comparative clinical trial evaluating the combination of adriamycin, DTIC, and vincristine, the combination of actinomycin D, cyclophosphamide, and vincristine, and a single agent, methyl-CCNU, in advanced sarcomas.
Creagan ET; Hahn RG; Ahmann DL; Edmonson JH; Bisel HF; Eagan RT
Cancer Treat Rep; 1976 Sep; 60(9):1385-7. PubMed ID: 189922
[No Abstract] [Full Text] [Related]
28. [Rhabdomyosarcoma in children (author's transl)].
Martínez-Mora J; Boix Ochoa J; Montané C; Gil Vernet JM; Broto J
An Esp Pediatr; 1976 Nov; 9(8):17-8. PubMed ID: 1015677
[TBL] [Abstract][Full Text] [Related]
29. Cyclophosphamide dose intensification during induction therapy for intermediate-risk pediatric rhabdomyosarcoma is feasible but does not improve outcome: a report from the soft tissue sarcoma committee of the children's oncology group.
Spunt SL; Smith LM; Ruymann FB; Qualman SJ; Donaldson SS; Rodeberg DA; Anderson JR; Crist WM; Link MP
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6072-9. PubMed ID: 15447992
[TBL] [Abstract][Full Text] [Related]
30. Embryonal rhabdomyosarcoma: five- year survival of a patient treated by radiation and chemotherapy.
Edland RW
Am J Roentgenol Radium Ther Nucl Med; 1967 Feb; 99(2):400-3. PubMed ID: 6020189
[No Abstract] [Full Text] [Related]
31. [Primary generalization in alveolar rhabdomyosarkom (author's transl)].
Gutjahr P; Hütteroth H; Meyer WW
Klin Padiatr; 1976 Jul; 188(4):372-8. PubMed ID: 988429
[TBL] [Abstract][Full Text] [Related]
32. Cooperative trial CWS-91 for localized soft tissue sarcoma in children, adolescents, and young adults.
Dantonello TM; Int-Veen C; Harms D; Leuschner I; Schmidt BF; Herbst M; Juergens H; Scheel-Walter HG; Bielack SS; Klingebiel T; Dickerhoff R; Kirsch S; Brecht I; Schmelzle R; Greulich M; Gadner H; Greiner J; Marky I; Treuner J; Koscielniak E
J Clin Oncol; 2009 Mar; 27(9):1446-55. PubMed ID: 19224858
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of rhabdomyosarcoma at the National Cancer Center Hospital].
Beppu Y; Fukuma H; Chuma H; Ise T; Ohira M
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 2):1603-13. PubMed ID: 3592704
[TBL] [Abstract][Full Text] [Related]
34. Embryonal rhabdomyosarcoma of the head and neck in children.
Sessions DG; Ragab AH; Vietti TJ; Biller HF; Ogura JH
Laryngoscope; 1973 Jun; 83(6):890-7. PubMed ID: 4351166
[No Abstract] [Full Text] [Related]
35. Multidisciplinary treatment of embryonal rhabdomyosarcoma in children.
Ghavimi F; Exelby PR; D'Angio GJ; Cham W; Lieberman PH; Tan C; Miké V; Murphy ML
Cancer; 1975 Mar; 35(3):677-86. PubMed ID: 1111936
[TBL] [Abstract][Full Text] [Related]
36. Childhood malignant tumors. Concurrent chemotherapy with dactinomycin and vincristine sulfate.
James DH; Hustu O; Wrenn EL; Johnson WW
JAMA; 1966 Sep; 197(12):1043-5. PubMed ID: 4288287
[No Abstract] [Full Text] [Related]
37. The influence of chemotherapy on the prognosis of rhabdomyosarcoma.
Ortega JA; Rivard GE; Isaacs H; Hittle RE; Hays DM; Pike MC; Karon MR
Med Pediatr Oncol; 1975; 1(3):227-34. PubMed ID: 1232531
[TBL] [Abstract][Full Text] [Related]
38. Extended combination therapy of childhood rhabdomyosarcoma.
Holton CP; Chapman KE; Lackey RW; Hatch EI; Baum ES; Favara BE
Cancer; 1973 Dec; 32(6):1310-6. PubMed ID: 4202189
[No Abstract] [Full Text] [Related]
39. Treatment of rhabdomyosarcoma in children with surgery, radiotherapy and chemotherapy.
Heyn R; Holland R; Joo P; Johnson D; Newton W; Tefft M; Breslow N; Hammond D
Med Pediatr Oncol; 1977; 3(1):21-32. PubMed ID: 840161
[TBL] [Abstract][Full Text] [Related]
40. Chemotherapy of malignant lesions unique in children.
Burgert EO; Mills SD
Mayo Clin Proc; 1966 Jun; 41(6):361-7. PubMed ID: 4287252
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
